Daniel Mulkerin

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz et al. · JAMA · 2017 · 852 citations · Full text

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group

Joseph Gibbons, Merrill J. Egorin, Ramesh K. Ramanathan et al. · Journal of Clinical Oncology · 2008 · 135 citations

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Chris H. Takimoto, Scot C. Remick, Sunil Sharma et al. · Journal of Clinical Oncology · 2003 · 120 citations

Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group

Ramesh K. Ramanathan, Merrill J. Egorin, Chris H. Takimoto et al. · Journal of Clinical Oncology · 2008 · 91 citations · Full text

A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma

Tabraiz A Mohammed, Kyle D. Holen, Renata Jaskula‐Sztul et al. · The Oncologist · 2011 · 89 citations · Full text